rs377022708
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_014049.5(ACAD9):c.1594C>T(p.Arg532Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,613,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R532R) has been classified as Likely benign.
Frequency
Consequence
NM_014049.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACAD9 | NM_014049.5 | c.1594C>T | p.Arg532Trp | missense_variant | 16/18 | ENST00000308982.12 | NP_054768.2 | |
CFAP92 | NM_001394090.1 | c.*248G>A | 3_prime_UTR_variant | 16/16 | ENST00000645291.3 | NP_001381019.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACAD9 | ENST00000308982.12 | c.1594C>T | p.Arg532Trp | missense_variant | 16/18 | 1 | NM_014049.5 | ENSP00000312618 | P1 | |
CFAP92 | ENST00000645291.3 | c.*248G>A | 3_prime_UTR_variant | 16/16 | NM_001394090.1 | ENSP00000496592 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461546Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 727046
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74336
ClinVar
Submissions by phenotype
Acyl-CoA dehydrogenase 9 deficiency Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 04, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2012 | - - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 04, 2016 | The R532W variant in the ACAD9 gene has been reported previously as a homozygous mutation in a consanguineous family. Affected individuals presented with easy fatigability and exercise intolerance (Gerards et al., 2011). Functional studies comparing wildtype and mutant ACAD9 indicate the R532W variant is unable to restore complex 1 activity in mutant cell lines (Gerards et al., 2011). The R532W variant was not observed with any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R532W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is moderately conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function, supporting the functional importance of this region of the protein. The R532W variant is a good candidate for a disease-causing mutation, however the possibility it may be a rare benign variant cannot be excluded. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 20, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 532 of the ACAD9 protein (p.Arg532Trp). This variant is present in population databases (rs377022708, gnomAD 0.0009%). This missense change has been observed in individuals with complex I deficiency (PMID: 20929961, 22499348, 30025539). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 30884). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACAD9 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change does not substantially affect ACAD9 function (PMID: 25721401). For these reasons, this variant has been classified as Pathogenic. - |
Mitochondrial complex I deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 21, 2022 | Variant summary: ACAD9 c.1594C>T (p.Arg532Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 249762 control chromosomes. c.1594C>T has been reported in the literature in multiple individuals affected with Mitochondrial Complex I Deficiency, Nuclear Type 20. Experimental evidence shows the variant to exhibite ACAD9 activity indistinguishable from wild type, leading authors to suggest that mutations in ACAD9 lead to CI deficiency independent of their effects on ACAD enzyme activity (Schiff_2015). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at